Bone Marrow-Derived Mesenchymal Stem Cells Attenuate Severe Acute Pancreatitis Via Regulation of Microrna-9 to Inhibit Necroptosis in Rats.

Guodong Song,Zhilong Ma,Dalu Liu,Daohai Qian,Jia Zhou,Hongbo Meng,Bo Zhou,Zhenshun Song
DOI: https://doi.org/10.1016/j.lfs.2019.03.019
IF: 6.78
2019-01-01
Life Sciences
Abstract:AIMS:Severe acute pancreatitis (SAP) is an acute disease of the digestive system accompanied by pancreatic necrosis. We have found that bone marrow-derived mesenchymal stem cells (BMSCs) can attenuate SAP, but the underlying mechanism remains unclear. The present study was conducted to explore the possible mechanisms by which BMSCs alleviate SAP.MAIN METHODS:BMSCs and BMSCs engineered to overexpress microRNA (miR)-9 (miR-9-BMSCs) were transplanted into rat models of SAP via the tail vein. Pancreatic acinar cells (PACs) were isolated from rat pancreatic tissues and induced by tumor necrosis factor-α (TNF-α) in vitro.KEY FINDINGS:miR-9-BMSCs significantly reduced the systemic inflammatory response, impeded the necroptosis signaling pathway and promoted regeneration of damaged pancreas in vivo. miR-9-BMSCs secreted miR-9, which targeted the gene encoding receptor interacting protein kinase 1 in PACs induced by TNF-α, to inhibit necroptosis and ameliorate SAP.SIGNIFICANCE:miR-9-BMSCs can reduce SAP-induced injury to pancreatic tissues and PACs by regulating miR-9 to suppress necroptosis.
What problem does this paper attempt to address?